Trial tests if Long-Term remission means patients can stop powerful drugs
NCT ID NCT07491913
Summary
This study aims to find out if patients with Takayasu arteritis who have been in stable remission for years can safely stop their biologic medications. It will enroll 40 patients who have been on these drugs for at least 3 years with no symptoms. Participants will slowly reduce their dose over 3 months, then stop completely if they remain well, and be monitored for a year to see if the disease stays away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TAKAYASU ARTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Marmara University Pendik Training and Research Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.